COL6A3 and hepatocellular carcinoma: Our analysis revealed that high expression of COL6A3 was associated with poorer prognosis in HCC patients from GSE14520 (Supplementary Fig. 1), and overexpression of MMP-9 was linked to poorer prognosis in HCC patients from TCGA (Supplementary Fig. 2).